- Type / Class
- Debt / NOTE 2.250% 3/0
- Market price (% of par)
- 100.32%
- Total 13F principal
- $239,416,100
- Principal change
- -$17,857,249
- Total reported market value
- $244,284,801
- Number of holders
- 21
- Value change
- -$22,593,875
- Number of buys
- 9
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 89422GAA5?
CUSIP 89422GAA5 identifies 89422GAA5 - TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89422GAA5:
Top shareholders of 89422GAA5 - TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 as of Q2 2022
As of 30 Jun 2022,
TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$239,416,100
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, Polar Asset Management Partners Inc., D. E. Shaw & Co., Inc., LAZARD ASSET MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, BlackRock Inc., AVIVA PLC, CITIGROUP INC, and Point72 Asset Management, L.P..
This page lists
21
institutional bondholders reporting positions
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price (% of par) | Principal | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
23
Q2 2022 holders
21
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.